Neupogen data

The Thousand Oaks, Calif., company said that findings reported at the Dallas meeting of the American Society of Clinical Oncology support use of the marrow-stimulating agent to enable the application of high doses of chemotherapy in cancer.

In a study of 184 patients with acute lymphoblastic leukemia, G-CSF significantly reduced (p<0.001) the time to recover counts of 1000 neutrophils/µl in both older patients (age??60 years; 15 versus 21 days) and younger patients (16 versus 29 days) receiving intensive, multi-agent chemotherapy. ...